Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs by Antonia Morita Iswari Saktiawati, Anca Vasiliu, Francesca Saluzzo, Onno W. Akkerman

Get full text

Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use? by Jan-Willem C. Alffenaar, Onno W. Akkerman, Hannah Yejin Kim, Simon Tiberi, Giovanni Battista Migliori

Get full text

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment by Lina Keutzer, Laurynas Mockeliunas, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Onno W. Akkerman, Ulrika S. H. Simonsson

Get full text

Update of drug-resistant tuberculosis treatment guidelines: A turning point by Elisa Vanino, Bianca Granozzi, Onno W. Akkerman, Marcela Munoz-Torrico, Fabrizio Palmieri, Barbara Seaworth, Simon Tiberi, Marina Tadolini

Get full text

Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients by Onno W. Akkerman, Lies ter Beek, Rosella Centis, Markus Maeurer, Dina Visca, Marcela Muñoz-Torrico, Simon Tiberi, Giovanni Battista Migliori

Get full text

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis by Laurynas Mockeliunas, Lina Keutzer, Marieke G. G. Sturkenboom, Mathieu S. Bolhuis, Lotte M. G. Hulskotte, Onno W. Akkerman, Ulrika S. H. Simonsson

Get full text

Individualized treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring by Mathieu S Bolhuis, Onno W Akkerman, Marieke G.G Sturkenboom, Wiel C.M de Lange, Tjip S van der Werf, Jan-Willem C Alffenaar

Get full text

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole by Anne M. Akkerman-Nijland, Bart L. Rottier, Joanne Holstein, Rik L.J. Winter, Daniel J. Touw, Onno W. Akkerman, Gerard H. Koppelman

Get full text

Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis. by Antonia M I Saktiawati, Ymkje Stienstra, Yanri W Subronto, Ning Rintiswati, Sumardi, Jan-Willem Gerritsen, Henny Oord, Onno W Akkerman, Tjip S van der Werf

Get full text

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients. by Marcel Hoppentocht, Onno W Akkerman, Paul Hagedoorn, Jan-Willem C Alffenaar, Tjip S van der Werf, Huib A M Kerstjens, Henderik W Frijlink, Anne H de Boer

Get full text

Eradication of in cystic fibrosis patients with inhalation of dry powder tobramycin by Anne M. Akkerman-Nijland, Mina Yousofi, Bart L. Rottier, Hester Van der Vaart, Johannes G. M. Burgerhof, Henderik W. Frijlink, Daan J. Touw, Gerard H. Koppelman, Onno W. Akkerman

Get full text

Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial by Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G. G. Sturkenboom, Jan-Willem C. Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W. Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra

Get full text

High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015. by Sofanne J Ravensbergen, Mariëtte Lokate, Darren Cornish, Eveline Kloeze, Alewijn Ott, Alex W Friedrich, Rob van Hest, Onno W Akkerman, Wiel C de Lange, Tjip S van der Werf, Erik Bathoorn, Ymkje Stienstra

Get full text

Variability and cost implications of three generations of the Roche LightCycler® 480. by Maria Dullaert-de Boer, Onno W Akkerman, Marloes Vermeer, Dorine L J Hess, Huib A M Kerstjens, Richard M Anthony, Tjip S van der Werf, Dick van Soolingen, Adri G M van der Zanden

Get full text

Corrigendum to “Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs” [Clin. Mass Spectrom. 14(Part A) (2019) 34–45] by Johanna Kuhlin, Marieke G.G. Sturkenboom, Samiksha Ghimire, Ioana Margineanu, Simone H.J. van den Elsen, Noviana Simbar, Onno W. Akkerman, Erwin M. Jongedijk, Remco A. Koster, Judith Bruchfeld, Daan J. Touw, Jan-Willem C. Alffenaar

Get full text

Malnutrition assessment methods in adult patients with tuberculosis: a systematic review by Huib A M Kerstjens, Tjip S van der Werf, Jan-Willem C Alffenaar, Simon Tiberi, Lies ter Beek, Mathieu S Bolhuis, Harriët Jager-Wittenaar, René X D Brijan, Marieke G G Sturkenboom, Wiel C M de Lange, Onno W Akkerman

Get full text

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study by Johanna P. van Gemert, Bart Luijk, Merel E. Hellemons, Klara A. Visser, Carina.M.E. Hansen, Renske van der Meer, C. Tji Gan, Hester van der Vaart, Onno W. Akkerman, Willie N. Steenhuis, Marieke Verkleij, Harry G.M. Heijerman, Erik A.M. Verschuuren

Get full text

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q by Paula Niewold, Douwe J. Dijkstra, Yi Cai, Delia Goletti, Fabrizio Palmieri, Krista E. van Meijgaarden, Frank A. W. Verreck, Onno W. Akkerman, Regina W. Hofland, Eveline M. Delemarre, Stefan Nierkens, Marije K. Verheul, Andrew J. Pollard, Jaap T. van Dissel, Tom H. M. Ottenhoff, Leendert A. Trouw, Simone A. Joosten

Get full text

Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis by Eveline M. Delemarre, Eveline M. Delemarre, Laura van Hoorn, Laura van Hoorn, Aik W. J. Bossink, Julia Drylewicz, Simone A. Joosten, Tom H. M. Ottenhoff, Onno W. Akkerman, Delia Goletti, Elisa Petruccioli, Assunta Navarra, Brigitte T. A. van den Broek, Sanne P. A. Paardekooper, Ineke van Haeften, Leo Koenderman, Leo Koenderman, Jan-Willem J. Lammers, Steven F. T. Thijsen, Regina W. Hofland, Regina W. Hofland, Stefan Nierkens, Stefan Nierkens

Get full text